LSO’S RESPONSE TO PMPRB INTERIM GUIDELINES CONSULATION

Published on July 18, 2022

All stakeholders have a role in ensuring Canada can attract research and new medicine launches as we rebuild from the pandemic. In this context, LSO has provided a number of general recommendations and considerations to help guide the PMPRB’s approach for its interim guidelines period and beyond. Read LSO’s submission...

The post LSO’S RESPONSE TO PMPRB INTERIM GUIDELINES CONSULATION appeared first on Life Sciences Ontario Site.